US Stock MarketDetailed Quotes
NUWE Nuwellis
- 0.2604
- -0.0174-6.26%
Close Apr 18 16:00 ET
1.77MMarket Cap-22P/E (TTM)
0.2900High0.2480Low526.59KVolume0.2866Open0.2778Pre Close139.51KTurnover7.76%Turnover RatioLossP/E (Static)6.80MShares5.730052wk High0.59P/B1.77MFloat Cap0.248052wk Low--Dividend TTM6.79MShs Float577080000.0000Historical High--Div YieldTTM15.12%Amplitude0.2480Historical Low0.2640Avg Price1Lot Size
About Nuwellis Company
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Company Profile
SymbolNUWE
Company NameNuwellis
Listing DateFeb 16, 2012
Founded1999
CEOMr. Nestor Jaramillo, Jr
MarketNASDAQ
Employees59
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address12988 Valley View Road
CityEden Prairie
ProvinceMinnesota
CountryUnited States of America
Zip Code55344
Phone1-952-345-4200
Company Executives
- Name
- Position
- Salary
- Nestor Jaramillo, Jr
- Director, President and Chief Executive Officer
- 1.12M
- Neil P. Ayotte, Esq.
- Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
- 372.79K
- Robert Benjamin Scott
- Chief Financial Officer and Principal Accounting Officer
- --
- John L. Erb
- Chairman of the Board
- 748.28K
- Dr. Maria Rosa Costanzo, M.D.
- Independent Director
- 47.00K
- Michael McCormick
- Lead Independent Director
- --
- Gregory D. Waller
- Independent Director
- 88.05K
- David Alan Mcdonald
- Independent Director
- --
- Dr. Archelle Georgiou, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg